Key Takeaways
- • Collective X Health, a women's health and performance intelligence platform, emerged from stealth with a $3.2 million oversubscribed pre-seed round.
- • The round was co-led by Council Capital and Anthemis Female Innovators Lab Fund, with participation from SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.
- • The company sells a B2B women's health intelligence API to wearables, digital health platforms, performance brands, and sports teams, with founding customers already licensing its data.
- • Its models are built on bias-corrected female research and data, addressing a long-standing gap in physiology data that has historically centered on male subjects.
Summary
San Francisco-based Collective X Health (CX) announced it has emerged from stealth with a $3.2 million oversubscribed pre-seed round, according to the company's announcement. The round was co-led by Council Capital and Anthemis Female Innovators Lab Fund. Participating investors included SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.
The company operates as a business-to-business women's health intelligence platform. It provides wearables, digital health platforms, performance brands, and sports teams with research-backed insights grounded in female physiology. Founding customers are licensing CX's women's health intelligence through an application programming interface (API), which the company says powers health, performance, and recovery insights.
CX states that its insights are built on bias-corrected female research and data. The company's stated end goal is to improve outcomes for women and to drive new research in women's health. The announcement did not disclose valuation, customer count, or revenue figures.
The company operates as a business-to-business women's health intelligence platform. It provides wearables, digital health platforms, performance brands, and sports teams with research-backed insights grounded in female physiology. Founding customers are licensing CX's women's health intelligence through an application programming interface (API), which the company says powers health, performance, and recovery insights.
CX states that its insights are built on bias-corrected female research and data. The company's stated end goal is to improve outcomes for women and to drive new research in women's health. The announcement did not disclose valuation, customer count, or revenue figures.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.